Cargando…

Voluntary wheel running in dystrophin-deficient (mdx) mice: Relationships between exercise parameters and exacerbation of the dystrophic phenotype

Voluntary wheel running can potentially be used to exacerbate the disease phenotype in dystrophin-deficient mdx mice. While it has been established that voluntary wheel running is highly variable between individuals, the key parameters of wheel running that impact the most on muscle pathology have n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smythe, Gayle M, White, Jason D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Muscular Dystrophy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269826/ https://www.ncbi.nlm.nih.gov/pubmed/22457847 http://dx.doi.org/10.1371/currents.RRN1295

Ejemplares similares

The Effects of Glucocorticoid and Voluntary Exercise Treatment on the Development of Thoracolumbar Kyphosis in Dystrophin-Deficient Mice
por: Brereton, Daniel, et al.
Publicado: (2012)

Alterations in the expression of leukemia inhibitory factor following exercise: comparisons between wild-type and mdx muscles
por: Hunt, Liam C, et al.
Publicado: (2011)

The different impact of a high fat diet on dystrophic mdx and control C57Bl/10 mice.
por: Radley-Crabb, Hannah G, et al.
Publicado: (2011)

Restoration of dystrophin expression using the Sleeping Beauty transposon
por: Muses, Sofia, et al.
Publicado: (2012)

Autophagy is Impaired in the Tibialis Anterior of Dystrophin Null Mice
por: Spitali, Pietro, et al.
Publicado: (2013)

Speckle tracking analysis of the left ventricular anterior wall shows significantly decreased relative radial strain patterns in dystrophin deficient mice after 9 months of age
por: Spurney, Christopher, et al.
Publicado: (2012)

Increased taurine in pre-weaned juvenile mdx mice greatly reduces the acute onset of myofibre necrosis and dystropathology and prevents inflammation
por: Terrill, Jessica R., et al.
Publicado: (2016)

Reprogramming efficiency and quality of induced Pluripotent Stem Cells (iPSCs) generated from muscle-derived fibroblasts of mdx mice at different ages
por: Wang, Bo, et al.
Publicado: (2011)

Dysferlin-deficient immortalized human myoblasts and myotubes as a useful tool to study dysferlinopathy
por: Philippi, Susanne, et al.
Publicado: (2012)

Repression of nuclear CELF activity can rescue CELF-regulated alternative splicing defects in skeletal muscle models of myotonic dystrophy
por: Berger, Dara S., et al.
Publicado: (2012)

DuchenneConnect Registry Report
por: Rangel, Vanessa, et al.
Publicado: (2012)

Percent-Predicted 6-Minute Walk Distance in Duchenne Muscular Dystrophy to Account for Maturational Influences
por: Henricson, Erik, et al.
Publicado: (2012)

The proteasomal inhibitor MG132 prevents muscular dystrophy in zebrafish
por: Winder, Steve J, et al.
Publicado: (2011)

Intramuscular Transplantation of Muscle Precursor Cells over-expressing MMP-9 improves Transplantation Success
por: Pichavant, Christophe, et al.
Publicado: (2011)

Human satellite cells: identification on human muscle fibres
por: Boldrin, Luisa, et al.
Publicado: (2012)

Clinic-Based Infant Screening for Duchenne Muscular Dystrophy: A Feasibility Study
por: Cyrus, Alissa, et al.
Publicado: (2012)

Guidance in Social and Ethical Issues Related to Clinical, Diagnostic Care and Novel Therapies for Hereditary Neuromuscular Rare Diseases: “Translating“ the Translational
por: McCormack, Pauline, et al.
Publicado: (2013)

The 6 Minute Walk Test and Performance of Upper Limb in Ambulant Duchenne Muscular Dystrophy Boys
por: Pane, Marika, et al.
Publicado: (2014)

Validity, Reliability, and Sensitivity of a 3D Vision Sensor-based Upper Extremity Reachable Workspace Evaluation in Neuromuscular Diseases
por: Han, Jay J., et al.
Publicado: (2013)

The Effect of 6-Thioguanine on Alternative Splicing and Antisense-Mediated Exon Skipping Treatment for Duchenne Muscular Dystrophy
por: Verhaart, Ingrid E. C., et al.
Publicado: (2012)

Proof of Concept of the Ability of the Kinect to Quantify Upper Extremity Function in Dystrophinopathy
por: Lowes, Linda P, et al.
Publicado: (2013)

New Recommendation on Biological Materials Could Hamper Muscular Dystrophy Research
por: McCormack, Pauline, et al.
Publicado: (2016)

Prednisone and Deflazacort in Duchenne Muscular Dystrophy: Do They Play a Different Role in Child Behavior and Perceived Quality of Life?
por: Sienko, Susan, et al.
Publicado: (2016)

Investigating Synthetic Oligonucleotide Targeting of Mir31 in Duchenne Muscular Dystrophy
por: Hildyard, John CW, et al.
Publicado: (2016)

Are Soy Products Effective in DMD?
por: Winder, Steve J, et al.
Publicado: (2018)

Collective Statement Regarding Patient Access to Approved Therapies from the Center Directors of Parent Project Muscular Dystrophy’s Certified Duchenne Care Centers
por: Ionita, Cristian, et al.
Publicado: (2018)

Health Care Transition Experiences of Males with Childhood-onset Duchenne and Becker Muscular Dystrophy: Findings from the Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet) Health Care Transitions and Other Life Experiences Survey
por: Paramsothy, Pangaja, et al.
Publicado: (2018)

A Pilot Survey Study of Adherence to Care Considerations for Duchenne Muscular Dystrophy
por: Conway, Kristin, et al.
Publicado: (2018)

Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular Dystrophy
por: Larkindale, Jane, et al.
Publicado: (2017)

Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice
por: Nogami, Ken'ichiro, et al.
Publicado: (2021)

Voluntary wheel running complements microdystrophin gene therapy to improve muscle function in mdx mice
por: Hamm, Shelby E., et al.
Publicado: (2021)

Voluntary wheel running complements microdystrophin gene therapy to improve muscle function in mdx mice
por: Hamm, Shelby E., et al.
Publicado: (2021)

Increased Neointimal Thickening in Dystrophin-Deficient mdx Mice
por: Rauch, Uwe, et al.
Publicado: (2012)

Increased levels of interleukin-6 exacerbate the dystrophic phenotype in mdx mice
por: Pelosi, Laura, et al.
Publicado: (2015)

Characterization of brain dystrophins absence and impact in dystrophin-deficient Dmd(mdx) rat model
por: Caudal, Dorian, et al.
Publicado: (2020)

Prolonged voluntary wheel running reveals unique adaptations in mdx mice treated with microdystrophin constructs ± the nNOS-binding site
por: Hamm, S. E., et al.
Publicado: (2023)

Effects of Voluntary Running Wheel Exercise-Induced Extracellular Vesicles on Anxiety
por: Yoon, Kyeong Jin, et al.
Publicado: (2021)

Successful histocompatible myoblast transplantation in dystrophin- deficient mdx mouse despite the production of antibodies against dystrophin
Publicado: (1995)

Peptide Nucleic Acid Promotes Systemic Dystrophin Expression and Functional Rescue in Dystrophin-deficient mdx Mice
por: Gao, Xianjun, et al.
Publicado: (2015)

Peptide Nucleic Acid Promotes Systemic Dystrophin Expression and Functional Rescue in Dystrophin-Deficient mdx Mice
por: Gao, Xianjun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oaohr01knth40ja7jn8q0f9ge8